| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0005 |